Journal of pineal research

Link Between Daily Melatonin Patterns in Urine and Bone Breakdown Levels in Blind Women

Updated

Abstract

Most blind women (N = 32/35, 91%) exhibited a significant 24-hour rhythm of melatonin levels.

  • A significant 24-hour rhythm of the bone resorption marker NTx was observed in 57% of the blind women studied.
  • No significant differences were found in the proportion of women with NTx rhythms based on visual light perception, entrainment, or reproductive status.
  • There was no correlation between the peak timings of melatonin and NTx among participants who had significant rhythms in both metabolites.
  • Perimenopausal women with light perception showed a significantly higher NTx area under the curve compared to others.
  • Findings do not support a direct influence of light, melatonin, or reproductive status on NTx rhythms.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

M.A.S.H. has received internal funding from Merrimack College, in-kind equipment from Labfront and Garmin Health, serves as a subject matter expert for easyJet plc, and serves as a consultant for TimeShifter Inc. She is an editorial board member for the Journal of Pineal Research. E.E.F-E. is co-owner of Baby Sleep Science. S.A.R. holds patents for (1) Method and device for preventing alterations in circadian rhythm (U.S. patent application Ser. No. 10/525,958), and (2) Methods and devices for improving sleep performance in subject exposed to light at night (U.S. Application No. 61/810,985); S.A.R. owns equity in Melcort Inc.; has received honoraria as an invited speaker and travel funds from FALK FOUNDATION E.V.; S.A.R. has received grant/research support from Seoul Semiconductor Co. Ltd., Biological Innovation and Optimization Systems LLC, Merck & Co. Inc., Pfizer Inc., Vanda Pharmaceuticals Inc., Lighting Science Group, and NIH. These interests were reviewed and managed by Brigham and Women’s Hospital and MassGeneralBrigham in accordance with their conflict of interest policies. S.H. has no potential conflicts of interest. P.W-E. is an associate editor for the Journal of Pineal Research but was not involved in the handling of this manuscript. She has received funding support from Jaquish Biomedicals and OsteoStrong. S.W.L. is currently a Visiting Professor at the Surrey Sleep Research Centre, University of Surrey, UK, and an Honorary Professor in the School of Psychological Sciences, Monash University, Australia. S.W.L. reports commercial interests from the last 3 years (2022–2025). S.W.L. has received consulting fees from Absolute Rest, Ashurst Risk Advisory Pty Ltd, Hintsa Performance AG, and Monash University, and has consulting contracts with Akili Interactive, Apex 2100 Ltd, Consumer Sleep Solutions, Illumalife, KBR Wyle Services, Light Cognitive, and Timeshifter Inc. He is the Chief Scientist and Founder of Timehifter Inc., and holds equity in the company. He has received honoraria and travel or accommodation expenses from Clifton College and CloserStill Media; and travel or accommodation expenses (no honoraria) from Energy Performance Lighting, IESANZ, the Royal Society of Medicine, and Wiley; and royalties from Oxford University Press and Monash University. He holds equity in iSleep pty. He has received a Clinical Research Support Agreement and Clinical Trial Agreement with Vanda Pharmaceuticals Inc. He is an unpaid Board Member of the Midwest Lighting Institute (non-profit). He holds several pending (US20190366032, US20210162164, US20220151552, and US20240353692) and one awarded (USD943612) patents assigned to Timeshifter Inc., and a pending patent assigned to Harvard University (US2025012131). He has served as a paid expert in legal proceedings related to light, sleep, and health.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free